NVEC

NVE Corporation (NVEC) - Q3 2026 Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended December 31, 2025 (Third Quarter of Fiscal Year 2026) and the nine months ended December 31, 2025. NVE Corporation develops and sells spintronic devices, including sensors and couplers, used for data acquisition and transmission. The company is a smaller reporting company with a fiscal year ending March 31.

Key Financial Metrics

Material Changes vs. Prior Period

• Quarterly Revenue Growth: Revenue increased 23% year-over-year in Q3, driven by a 16.5% increase in product sales (both defense and non-defense) and a 335% surge in contract research and development revenue due to new contracts.
• Margin Compression: Gross margin declined to 78.6% from 84.2% in the prior year quarter. Management attributes this to a less profitable product mix and a higher proportion of distributor sales, which carry lower margins than direct sales.
• Expense Reduction: Total operating expenses decreased 12% year-over-year. R&D expenses fell 8.5% due to the completion of wafer-level chip scale packaging activities, and SG&A expenses dropped 19% due to timing of marketing activities and resource reallocation.
• Tax Rate Increase: The effective tax rate rose to 20% in Q3 from 15% in the prior year, primarily due to unfavorable non-cash impacts of tax law changes on certain deductions.
• YTD Performance: For the nine-month period, revenue was flat (+0.4%), but net income decreased 8% to $10.27 million due to margin compression and higher tax rates, despite lower operating expenses.

Guidance, Outlook, and Risks

• Tax Outlook: Management expects a full-year effective tax rate of 16% to 17% for fiscal 2026. This projection accounts for unfavorable tax law changes but includes an anticipated $700,000 to $1,000,000 in advanced manufacturing investment tax credits.
• Cash Tax Savings: The company expects accelerated deductions of previously unamortized R&D expenses (per the Federal budget reconciliation bill enacted July 4, 2025) to reduce cash taxes for the full fiscal year by approximately $1.1 million.
• Dividends: A quarterly dividend of $1.00 per share was declared on January 21, 2026, payable February 27, 2026. The company plans to fund dividends through operating cash flow and maturing securities.
• Key Risks:
  • Customer Concentration: Reliance on several large customers, including Abbott Laboratories (agreement extended to December 31, 2027).
  • Regulatory Changes: New Minnesota state legislation effective January 1, 2026, mandates paid leave, increasing employment costs and potential absence risks.
  • Trade Barriers: Risks related to tariffs, customs, and duties.

Investor Verification Checklist

• Margin Sustainability: Verify if the shift toward distributor sales is a temporary trend or a structural change that will permanently lower gross margins.
• Tax Credit Realization: Confirm the timing and certainty of the anticipated $700k-$1M advanced manufacturing tax credits to validate the 16-17% full-year tax rate guidance.
• Liquidity vs. Dividends: Assess the impact of consistent $1.00 quarterly dividends on the cash balance, noting the $4.6M decrease in cash equivalents over the nine-month period.
• Contract R&D Volatility: Monitor the sustainability of the 335% increase in contract R&D revenue, as this segment is subject to contract timing and renewal risks.
• Fixed Asset Investment: Review the $2.18M in fixed asset purchases (production equipment) to ensure alignment with future revenue growth projections.